Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

J. T. Roberts; H. von der Maase; L. Sengeløv; P. F. Conte; L. Dogliotti; T. Oliver; M. J. Moore; A. Zimmermann; and M. Arning

首页> 外文期刊>Annals of Oncology >Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

【24h】

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

机译：比较吉西他滨/顺铂和甲氨蝶呤/长春碱/阿霉素/顺铂在局部晚期和转移性膀胱癌患者中的随机试验的长期生存结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To compare long-term survival in patients with locally advanced and metastatic transitional cell carcinoma (TCC) of the urothelium treated with gemcitabine plus cisplatin (GC) or methotrexate/vinblastine/doxorubicin/cisplatin (MVAC).

机译：目的：比较吉西他滨联合顺铂（GC）或甲氨蝶呤/长春碱/阿霉素/顺铂（MVAC）治疗的尿路上皮局部晚期和转移性移行细胞癌（TCC）患者的长期生存率。

著录项

来源
《Annals of Oncology》 |2006年第5期|v118-v122|共5页
作者
J. T. Roberts; H. von der Maase; L. Sengeløv; P. F. Conte; L. Dogliotti; T. Oliver; M. J. Moore; A. Zimmermann; and M. Arning;
展开▼
作者单位

Department of Oncology Aarhus University Hospital Denmark;

Department of Oncology Herlev University Hospital Denmark;

Northern Centre for Cancer Treatment Newcastle General Hospital UK;

Santa Chiara Hospital Italy;

University of Torino St. Luigi Hospital Orbassano Italy;

St. Bartholomew's Hospital UK;

The Princess Margaret Hospital Canada;

Eli Lilly and Company IN USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Long-term survival results of a randomized trial comparing gemcitabine plus Cisplatin, with methotrexate, vinblastine, Doxorubicin, plus Cisplatin in patients with bladder cancer. [J] . von der Maase H, Sengelov L, Roberts JT, Journal of Clinical Oncology . 2005,第21期

机译：吉西他滨加顺铂与甲氨蝶呤，长春碱，阿霉素和顺铂在膀胱癌患者中进行比较的一项随机试验的长期生存结果。
2. Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial [J] . Christian Pfister, Valentin Harter, Yves Allory, Contemporary Clinical Trials Communications . 2020,第4期

机译：随机对照甲尾甲醇三甲产蛋白，长霉素，多柔比星和顺铂（DD-MVAC）或吉西他滨和顺铂（GC）的患者为膀胱局部晚期过渡细胞癌患者的患者的随机致密甲氨蝶呤（DD-MVAC）或吉西他滨和顺铂（GC）的设计。法国Getug / AFU V05 Vesper试用
3. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. [J] . von der-Maase-H, Hansen SW, Roberts JT, Journal of Clinical Oncology . 2000,第17期

机译：吉西他滨和顺铂与甲氨蝶呤，长春碱，阿霉素和顺铂治疗晚期或转移性膀胱癌：一项大型，随机，跨国，多中心，III期研究的结果。
4. Multimodality Treatment of Locally-Advanced Breast Cancer Using 6.3 MeV Fast Neutrons and Quality of Life in Patients in Long-term Follow-up [C] . STARTSEVA Zhanna, MUSABAEVA Ludmila, LISIN Valerij International Conference on Physical-Technical Problems of Nuclear Science, Energy Generation and Power Industry . 2015

机译：在长期随访中使用6.3 MeV快速中子和患者生活质量的局部晚期乳腺癌的多模
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Design of a randomized controlled phase III study of dose dense methotrexate vinblastine doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial [O] . Christian Pfister, Valentin Harter, Yves Allory, 2020

机译：剂量密集的甲氨蝶呤长春碱阿霉素和顺铂（dd-MVAC）或吉西他滨和顺铂（GC）作为围手术期化疗的局部晚期膀胱癌患者的随机对照III期研究设计。法国GETUG / AFU V05 VESPER试用版
7. Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial [O] . Christian Pfister, Valentin Harter, Yves Allory, 2020

机译：随机对照甲尾甲醇三甲产蛋白，长霉素，多柔比星和顺铂（DD-MVAC）或吉西他滨和顺铂（GC）的患者为膀胱局部晚期过渡细胞癌患者的患者的随机致密甲氨蝶呤（DD-MVAC）或吉西他滨和顺铂（GC）的设计。法国Getug / AFU V05 Vesper试用

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

摘要

著录项

相似文献

相关主题

期刊订阅